Study Reports Immediate Pain Freedom in 14 of 15 Patients all Patients Achieved Favorable Pain Outcomes at a Mean Six-Month Follow-Up Multi-Contact Probe Technology Enabled Mapping and Treatment of Trigeminal Nerve Distr
Why Is NeuroOne Medical Technologies Corporation (NMTC) Stock Down Today?
Updated Nov 22, 2026 5:56 AM ET ยท Prev Close $0.67
Session Regime & Catalyst Assessment
68% Signal ConvictionNeuroOne Medical Technologies Corporation Pulling Back 3.38% on 1.50x Relative Volume
NeuroOne Medical Technologies Corporation (NMTC) is pulling back 3.38% (-$0.02) to $0.65 on 1.50x average session volume. Relative to benchmarks, NMTC is trading in line with the S&P 500 (+0.26% alpha). 14-day RSI stands at 31.2, keeping momentum in a bearish regime.
Study Reports Immediate Pain Freedom in 14 of 15 Patients all Patients Achieved Favorable Pain Outcomes at a Mean Six-Month Follow-Up Multi-Contact Probe Technology Enabled Mapping and Treatment of Trigeminal Nerve Distr
Price ($0.65) trades relative to 20-day SMA ($0.83) and 50-day SMA ($1.03).
Market & Sector Relative Strength
NMTC trading in line with the S&P 500 (+0.26% alpha)Recent NMTC Catalyst Headlines
Verified WireNeuroOne s FDA 510 k -Cleared OneRF Trigeminal Nerve Ablation System Offers Hope for Patients Suffering from Trigeminal Neuralgia Eden Prairie, Minn., Oct. 27, 2026 Globe Newswire -- NeuroOne Medical Technologies Corpora
Major Commercial Milestone Represents Important Step Toward Potential Long-Term Collaborations with Global Pharmaceutical Companies Eden Prairie, Minn., Oct. 22, 2026 Globe Newswire -- NeuroOne Medical Technologies Corpo
New NIH Award will Initially Provide NeuroOne Approximately 200,000 through April 2027 Eden Prairie, Minn., Oct. 08, 2026 Globe Newswire -- NeuroOne Medical Technologies Corporation Nasdaq NMTC NeuroOne or the Company ,
1โ3 Day Expected Range & Key Level
54% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $0.61 (session support) for directional breakout confirmation.
Technical Regime (NMTC)
BEARISH MA TRENDRetail & Crowd Sentiment
Very BearishBearish sentiment dominates on StockTwits as one user expresses delays in finalizing remodeling issues for $NMTC, potentially pushing back their return before Thanksgiving.
About NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development โฆ
Get Instant NMTC Catalyst Alerts
Receive an email alert when NMTC triggers an unusual volume breakout, options sweep, or rating shift.
NMTC Session & Catalyst FAQ
Why is NMTC stock down today?
NeuroOne Medical Technologies Corporation (NMTC) is pulling back 3.38% (-$0.02) to $0.65 on 1.50x average session volume. Relative to benchmarks, NMTC is trading in line with the S&P 500 (+0.26% alpha). 14-day RSI stands at 31.2, keeping momentum in a bearish regime.
Is NMTC stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 1.50x relative volume (high participation). Our multi-factor model currently rates NMTC as HOLD. Review full valuation, quality, and timing signals on the NMTC Buy or Sell Decision Brief โ
What is NMTC's intrinsic value and expected trading range?
At $0.65, NMTC's modeled 1-to-3 session range is $0.61 โ $0.69, with a key inflection level at $0.61 (session support). Compare current price against multi-year cash flow projections in the NMTC Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for NMTC?
RSI at 31.2 reflects soft below-midline momentum. NMTC trades at $0.65 relative to its 20-day SMA ($0.83) and 50-day SMA ($1.03), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.